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MaBACKGROUND Cumulative blood pressure (BP) exposure may adversely inﬂuence myocardial function, predisposing
individuals to heart failure later in life.
OBJECTIVES This study sought to investigate how cumulative exposure to higher BP inﬂuences left ventricular (LV)
function during young to middle adulthood.
METHODS The CARDIA (Coronary Artery Risk Development in Young Adults) study prospectively enrolled 5,115 healthy
African Americans and whites in 1985 and 1986 (baseline). At the year 25 examination, LV function was measured by
2-dimensional echocardiography; cardiac deformation was assessed in detail by speckle-tracking echocardiography.
We used cumulative exposure of BP through baseline and up to the year 25 examination (millimeters of mercury  year)
to represent long-term exposure to BP levels. Linear regression and logistic regression were used to quantify the
association of BP measured repeatedly through early adulthood (18 to 30 years of age) up to middle age (43 to 55 years).
RESULTS Among 2,479 participants, cumulative BP measures were not related to LV ejection fraction; however, high
cumulative exposure to systolic blood pressure (SBP) and diastolic blood pressure (DBP) were associated with lower
longitudinal strain rate (both p < 0.001). For diastolic function, higher cumulative exposures to SBP and DBP were
associated with low early diastolic longitudinal peak strain rate. Of note, higher DBP (per SD increment) had a stronger
association with diastolic dysfunction compared with SBP.
CONCLUSIONS Higher cumulative exposure to BP over 25 years from young adulthood to middle age is associated
with incipient LV systolic and diastolic dysfunction in middle age. (J Am Coll Cardiol 2015;65:2679–87)
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ABBR EV I A T I ON S
AND ACRONYMS
BP = blood pressure
CI = conﬁdence interval
DBP = diastolic blood pressure
Ecc = circumferential peak
systolic strain
Ecc_SRe = circumferential
peak early diastolic strain rate
Ecc_SRs = circumferential
peak systolic strain rate
Ell = 4-chamber longitudinal
peak strain
Ell_SRe = 4-chamber
longitudinal peak early
diastolic strain rate
Ell_SRs = 4-chamber
longitudinal peak systolic
strain rate
Err = radial peak strain
Err_SRs = radial peak systolic
strain rate
HF = heart failure
LV = left ventricular
LVEF = left ventricular ejection
fraction
LVMI = left ventricular mass
index
MAP = mean arterial pressure
OR = odds ratio
PP = pulse pressure
SBP = systolic blood pressure
STE = speckle-tracking
echocardiography
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2680B lood pressure (BP) at the higher endof the population distribution mayrepresent a chronic exposure that in-
jures the cardiovascular system. Cumulative
BP exposure from young adulthood to middle
age may adversely inﬂuence myocardial
function and predispose individuals to heart
failure (HF) and other cardiovascular disease
later in life. The 2005 guidelines for the diag-
nosis and treatment of HF from the American
College of Cardiology and American Heart
Association highlighted the importance of
early recognition of subclinical cardiac dis-
ease and of noninvasive tests in the clinical
evaluation of HF (1).SEE PAGE 2688Speckle-tracking echocardiography (STE)
offers the opportunity to evaluate subclinical
markers of left ventricular (LV) dysfunction,
and global myocardial strain assessed by STE
has been described as a better predictor of
future HF and other cardiovascular end-
points compared with left ventricular ejec-
tion fraction (LVEF) (2,3). Hypertension has
been related to reduced global myocardial
deformation as a precursor of HF (4,5), and,
in turn, global myocardial deformation pa-
rameters (longitudinal and circumferential
shortening and radial thickening) have been
directly related to HF (6,7).
Our main objective was to investigate how
cumulative exposure to high BP from young
to middle adulthood inﬂuences LV function.In the CARDIA (Coronary Artery Risk Development in
Young Adults) study, multiple repeated measures of
BP and other cardiovascular risk factors were recor-
ded over a 25-year timespan, starting during early
adulthood (ages 18 to 30 years). In this report, we
demonstrate the cumulative effect of BP exposure to
conventional echocardiographic measures of LV sys-
tolic and diastolic function, as well as LV strain
measures assessed by STE, also used as markers of
subclinical LV dysfunction.
METHODS
PARTICIPANTS. The CARDIA study is a multicenter
prospective investigation that enrolled 5,115 healthy
African-American and white men and women in 1985
and 1986 (year 0) from 4 U.S. ﬁeld centers (Birming-
ham, Alabama; Oakland, California; Chicago, Illinois;
Minneapolis, Minnesota). Participants were followed
prospectively in 7 subsequent examinations. TheInstitutional Review Boards at each study site
approved the study protocols, and written informed
consent was obtained from all participants. Of 3,498
participants attending the year 25 (2010 to 2011) ex-
amination, 3,474 underwent standard echocardiog-
raphy and STE assessment. We excluded participants
with incomplete BP measurement during 25 years of
follow-up (n ¼ 995). The remaining 2,479 participants
with complete longitudinal datasets were included in
the analyses. At baseline, the included participants
were slightly older (25.3 vs. 24.5 years) and more
female than male (1,409 vs. 1,070), and had a lower
percentage of blacks (41.4% vs. 61.1%), higher
educational attainment (14.2 vs. 13.4 years), and
lower baseline systolic blood pressure (SBP) (109.8 vs.
110.9 mm Hg; all p < 0.01) compared with those not
included in this study (n ¼ 2,636) (Online Table 1).
Standardized protocols were used to measure
height, weight, heart rate, BP, lipids, glucose, smoking
status, educational level, and physical activity (8,9).
Weight and height were measured using a standard
balance beam scale. Bodymass indexwas calculated as
weight (kilograms) divided by height in meters
squared. We used the average of the second and third
of 3 BP measurements using random-zero sphygmo-
manometry performed at 1-min intervals after the
participant had been sitting quietly for 5 min in a
still room (year 0 to 15) and a BP monitor (year 20 to 25;
Omron Healthcare Inc., Lake Forest, Illinois) (10). A
calibration studywas performed, and values calibrated
to the sphygmomanometric measures were used for
year 20 and year 25 BP measurements. We used reca-
libratedmeasures (10). Pulse pressure (PP) as the index
of pulsatile component of BP was calculated as SBP
minus diastolic blood pressure (DBP); mean arterial
pressure (MAP) was calculated as: DBP þ (1/3 PP). The
presence of diabetes was assessed at each examina-
tion on the basis of a combination of medication use
for diabetes (every examination), fasting plasma
glucose $126 mg/dl (examination years 0, 7, 10, 15, 20,
and 25), 2-h glucose $200 mg/dl (years 10, 20, and 25),
or glycosylated hemoglobin $6.5% (years 20 and 25).
Total cholesterol was measured in fasting plasma
samples and determined by enzymatic procedures.
We calculated the cumulative exposure of BP for
each participant over 25 years from age 18 to 30 years
to age 43 to 55 years as millimeters of mercury 
year at each clinic visit to represent long-term
exposure to BP levels. We deﬁned this BP product
for each participant’s accumulated exposure to BP.
We used the area under the BP curve over 25 years as
a covariate in the univariable and multivariable
analyses. Calculations were performed for SBP, DBP,
PP, and MAP.
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2681ECHOCARDIOGRAPHIC AND SPECKLE-TRACKING
ANALYSIS. Experienced sonographers performed
Doppler echocardiography and 2-dimensional–guided
M-mode echocardiography using an Artida car-
diac ultrasound scanner (Toshiba Medical Systems,
Otawara, Japan) using standardized protocols across
all ﬁeld centers. The sonographers made measure-
ments from digitized images using a standard off-line
image analysis software system (Digisonics, Inc.,
Houston, Texas). LVEF and left atrial volume were
measured from the apical 4-chamber view on the
basis of the American Society of Echocardiography
guidelines; LV mass was derived from the Devereux
formula using the American Society of Echocardiog-
raphy guidelines (11). Left atrial volume and LV mass
were indexed to body surface area (left atrial volume
index and left ventricular mass index [LVMI]). In the
diastolic functional parameters, peak velocities of the
early phase (E), late phase (A) of the mitral inﬂow,
and their ratio (E/A ratio) were measured from pulsed
Doppler echocardiography recordings of transmitral
ﬂow; early peak diastolic mitral annular velocity (e’)
at the septal mitral annulus was measured using tis-
sue Doppler imaging (12). E/e’ ratio was calculated as
an index of LV ﬁlling pressures.
STE for myocardial strain and strain rate mea-
surements was performed ofﬂine with dedicated
semiautomated 2-dimensional STE software (Toshiba
Medical Systems) only at year 25 (13). Three cardiac
cycles from each view were recorded for ofﬂine ana-
lyses. Average frame rate was 46.2 frames per second
with mean heart rate <70 beats/min on the basis of
consensus (14). Strain was calculated as the peak
systolic change in segment length relative to its end-
diastolic value. Longitudinal strain and strain rate
curves were assessed from 4-chamber views.
Circumferential strain and strain rate were assessed
from the short-axis view at mid-ventricular level. STE
images were analyzed on a 6-segment basis for
endocardial, mid-wall, and epicardial contours for
each view. The mid-wall layer in each segment was
analyzed for global longitudinal and circumferential
strain and strain rate. The image set in each view was
considered inadequate for STE if 4 or more segments
had been excluded because of less optimal tracking.
Global strain values were calculated as the average of
segmental peak strains. Global strain rate values were
also calculated from the average of segmental peak
values for each phase (in s1). STE indices of systolic
cardiac deformation at the year 25 examination
included 4-chamber longitudinal peak systolic strain
(Ell), circumferential peak systolic strain (Ecc), radial
peak systolic strain (Err), 4-chamber longitudinal
systolic strain rate (Ell_SRs), circumferential systolicstrain rate (Ecc_SRs), and radial systolic strain rate
(Err_SRs). Diastolic STE indices were peak early dia-
stolic strain rate in the 4-chamber longitudinal
(Ell_SRe), circumferential (Ecc_SRe), and radial
(Err_SRe).
STATISTICAL ANALYSIS. Descriptive statistics were
displayed using means and standard deviations for
continuous variables and group proportions for cat-
egorical variables. Student t tests were used to
compare means between blacks and whites of
both sexes. Multivariable linear regression models
assessed the longitudinal associations between year
0 BP parameters and STE parameters and conven-
tional echocardiographic parameters measured at the
year 25 examination. Multivariable models were
adjusted for the following traditional cardiovascular
disease risk factors: Model 1 included age at year 25,
sex, race, and ﬁeld centers as demographic variables;
Model 2 included Model 1 and average level of body
mass index (kilograms/meters squared), physical
activity (exercise unit), alcohol intake (milliliters),
heart rate (beats/min), total cholesterol (milligrams/
deciliter), diabetes, and current smoking status
at year 25 as cardiovascular risk factors; Model 3
included Model 2 and LVMI as an LV structural
parameter; and Model 4 included Model 3 and use of
antihypertensive medication at year 25.
For categorical analyses of clinically signiﬁcant
cardiac dysfunction, systolic dysfunction was deﬁned
as LVEF <50% and diastolic dysfunction as E/e’ ratio
>15 (15–17). We explored relationships between BP
(per SD higher) over 25 years and clinically relevant
LV dysfunction at year 25 using multivariable logistic
regression analysis, which we evaluated accounting
for similar covariates, reporting odds ratios (ORs) and
95% conﬁdence intervals (CIs).
We explored the relationship between the deciles
of cumulative BP exposure and standardized LV
function. We compared the deciles of cumulative BP
for LV function compared with the lowest BP decile
(0% to 10%) group.
A 2-sided p value of <0.05 was considered for
statistical signiﬁcance. All statistical analyses were
performed using SAS version 9.3 for Windows (SAS
Institute Inc., Cary, North Carolina).
RESULTS
Cohort characteristics at year 25 are shown in Table 1.
The mean age at this time point was 50  3.6 years,
56.8% of all participants were women, and 60.0%
were white. Mean values for conventional echocar-
diographic parameters were within the normal range
in mid-age (43 to 55 years). In this CARDIA cohort,
TABLE 1 Participant Characteristics at Year 25 (n ¼ 2,479)
n Men n Women p Value
Age, yrs 1,070 50.4  3.6 1,409 50.4  3.5 0.7788
Black 381 35.6 644 45.7 <0.0001
Weight, kg 1,070 93.2  20.0 1,409 82.2  22.0 <0.0001
BMI, kg/m2 1,067 29.4  5.8 1,409 30.4  8.0 0.0007
Heart rate, beats/min 1,070 65.6  7.34 1,409 69.0  6.8 <0.0001
SBP, mm Hg 1,070 121.2  14.2 1,409 117.5  17.2 <0.0001
DBP, mm Hg 1,070 75.3  10.6 1,409 73.6  11.6 0.0002
Cumulative exposure to SBP,
mm Hg  yr
1,070 2,875.1  228.9 1,409 2,721.1  256.8 <0.0001
Cumulative exposure to DBP,
mm Hg  yr
1,070 1,834.0  181.4 1,409 1,741.5  192.9 <0.0001
Cumulative exposure to PP,
mm Hg  yr
1,070 1,041.0  137.7 1,409 979.5  143.1 <0.0001
Cumulative exposure to MAP,
mm Hg  yr
1,070 2,181.1  187.6 1,409 2,068.0  205.5 <0.0001
Diabetes 82 7.7 97 6.9 0.4578
Current smoker 155 14.7 188 13.5 0.4242
Drinker 693 65.1 683 48.9 <0.0001
Antihypertensive medication 279 26.1 365 25.9 0.9239
Educational level, yrs 1,067 15.3  2.8 1,406 15.4  2.6 0.3294
Physical activity, EU 1,066 414.7  295.2 1,401 285.3  244.2 <0.0001
Fasting glucose, mg/dl 1,065 104.4  33.7 1,401 95.6  23.7 <0.0001
Total cholesterol, mg/dl 1,065 189.0  37.4 1,402 195.2  35.9 <0.0001
HDL cholesterol, mg/dl 1,065 50.5  15.6 1,402 63.8  17.5 <0.0001
LDL cholesterol, mg/dl 1,049 113.0  33.5 1,396 111.5  31.6 0.2736
Echocardiographic parameters
LVEF, % 1,003 60.8  7.3 1,285 62.5  6.8 <0.0001
E/A ratio 1,055 1.33  0.35 1,376 1.29  0.38 0.0228
Deceleration time, ms 1,049 179.4  40.1 1,371 176.9  39.4 0.1292
LAV/BSA ml/m2 1,054 25.34  7.08 1,386 25.05  7.16 0.3217
e’, cm/s 1,045 10.45  2.20 1,377 10.65  2.36 0.0328
E/e’ ratio 1,043 7.48  2.13 1,361 8.03  2.29 <0.0001
Ell, % 941 14.70  2.30 1,222 15.50  2.44 <0.0001
Ecc, % 943 15.02  2.70 1,259 15.67  2.85 <0.0001
Err, % 943 37.80  12.02 1,259 37.18  12.38 0.2378
Ell_SRs, sec1 941 0.65  0.12 1,222 0.67  0.12 0.0013
Ecc_SRs, sec1 860 0.69  0.15 1,125 0.69  0.15 0.9715
Err_SRs, sec1 860 1.81  0.64 1,125 1.74  0.62 0.0138
Ell_SRe, sec1 937 0.77  0.21 1,219 0.87  0.27 <0.0001
Ecc_SRe, sec1 859 0.77  0.31 1,122 0.84  0.31 <0.0001
Err_SRe, sec1 860 2.27  1.30 1,125 2.32  1.29 0.4201
Values are n, mean  SD, or %. Comparisons across sex or race were by Student t test.
BSA ¼ body surface area; BMI ¼ body mass index; DBP ¼ diastolic blood pressure; e’ ¼ peak early diastolic
mitral annular velocity; E/A ¼ peak velocities of the early phase and late phase of the mitral inﬂow; Ecc ¼
circumferential peak systolic strain; Ecc_SRe ¼ circumferential peak early diastolic strain rate; Ecc_SRs ¼
circumferential peak systolic strain rate; E/e’ ¼ ratio of early peak diastolic mitral velocity/peak early diastolic
mitral annular velocity; Ell ¼ longitudinal peak systolic strain; Ell_SRe ¼ longitudinal peak early diastolic strain
rate; Ell_SRs ¼ longitudinal peak systolic strain rate; Err ¼ radial peak systolic strain; Err_SRe ¼ radial peak early
diastolic strain rate; Err_SRs ¼ radial peak systolic strain rate; EU ¼ exercise unit; HDL ¼ high-density lipoprotein;
LAV ¼ left atrium volume; LDL ¼ low-density lipoprotein; LVEF ¼ left ventricular ejection fraction; MAP ¼ mean
arterial pressure; PP ¼ pulse pressure; SBP ¼ systolic blood pressure.
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DBP and MAP increased from baseline to the fourth
decade and then plateaued (Central Illustration,
Online Figure 1). PP decreased until 40 years of age
and then increased after age 40 years. Black men and
women had higher SBP, DBP, and MAP levelscompared with whites more than 25 years of age. Men
had higher PP than women.
LV SYSTOLIC AND DIASTOLIC FUNCTION. LV sys-
tolic dysfunction (LVEF <50%) was present in 70
participants, diastolic dysfunction (E/e’ ratio >15) was
present in 69 participants, and systolic or diastolic
dysfunction was present in 135 participants. Cumu-
lative BPs (SBP, DBP, MAP, and PP) were not associ-
ated with the likelihood of having an ejection
fraction <50% measured by conventional echocardi-
ography (Table 2, Online Table 2); meanwhile, higher
SBP (OR: 1.46; 95% CI: 1.09 to 1.94), DBP (OR: 1.69;
95% CI: 1.23 to 2.33), and MAP (OR: 1.40; 95% CI: 1.10
to 1.78) were predictors of diastolic dysfunction after
full adjustment. Higher DBP had the strongest asso-
ciation with diastolic dysfunction. Both higher SBP
(OR: 1.38; 95% CI: 1.10 to 1.73) and DBP (OR: 1.34; 95%
CI: 1.05 to 1.70) were predictors of the presence of
systolic or diastolic dysfunction after full adjustment.
Higher deciles of cumulative SBP and DBP were
associated with low Ell_SRs (p < 0.05) compared with
the lowest BP decile; however, neither SBP nor
DBP was associated with LVEF (Central Illustration).
Results for MAP were similar (Online Figure 2).
Cumulative exposure to BP parameters (SBP, DBP,
and PP) was not related to LVEF measured by con-
ventional echocardiography (Table 3, Online Table 3);
however, high cumulative exposure to SBP, DBP, and
MAP were independently associated with low Ell and
Ell_SRs. The magnitudes of the standardized b-co-
efﬁcients for DBP (0.119 for Ell and 0.107 for Ell_SRs;
all p < 0.001) in relation to Ell and Ell_SRs were higher
than those for SBP (0.078 for Ell; p < 0.05; and
0.086 for Ell_SRs; p < 0.005) and MAP (0.112 for Ell;
p < 0.001; and 0.080 for Ell_SRs; p < 0.005). High
cumulative exposure to PP was independently asso-
ciated with Ecc (standardized b-coefﬁcient ¼ 0.06;
p < 0.05). High cumulative exposure to SBP (0.118 for
Err and 0.115 for Err_SRs; all p < 0.001) and PP (0.105
for Err and 0.106 for Err_SRs; all p < 0.001) was
independently associated with high Err and Err_SRs.
LVMI attenuated the relationship of BP to LV systolic
function in Model 3, but antihypertensive medica-
tions did not attenuate these relationships in
Model 4. Prediction of LV function from BP at year
0 (baseline) was less powerful than cumulative BP
over 25 years (Online Table 4).
Higher deciles of cumulative SBP and DBP were
associated with increased E/e’ ratio (p < 0.05), and
higher deciles of cumulative SBP and DBP were
associated with reduced Ell_SRe (p < 0.05) compared
with the lowest BP decile (Central Illustration). Similar
relationships were found for MAP (Online Figure 2).
CENTRAL ILLUSTRATION Early Adulthood Blood Pressure and Middle-Age Left Ventricular Function
Kishi, S. et al. J Am Coll Cardiol. 2015; 65(25):2679–87.
Blood pressure (BP) trends with increasing age. The trajectory slope shows mean systolic blood pressure (SBP) and diastolic blood pressure (DBP) with increasing age for
white and black men and women. All BP measurements over 25 years were within guideline acceptable range (A and B). Systolic and diastolic function with increasing
cumulative SBP and DBP. (C) For left ventricular (LV) systolic function, there were no differences in left ventricular ejection fraction (LVEF) among cumulative SBP
deciles; meanwhile, higher deciles of cumulative SBP produced a lower 4-chamber longitudinal peak systolic strain rate (Ell_SRs) compared with the lowest SBP (0% to
10%) decile. For LV diastolic function, early peak diastolic mitral velocity/peak early diastolic mitral annular velocity (E/e0) ratio increased in higher deciles of cumulative
SBP compared with the lowest decile. Higher deciles of cumulative SBP were associated with lower 4-chamber longitudinal peak early diastolic strain rate (Ell_SRe)
versus the lowest decile. (D) In considering cumulative DBP deciles, the same trends were seen for LVEF, as well as when comparing the higher deciles with the lowest
group for Ell_SRs, E/e0 ratio, and Ell_SRe.
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independently associated with low E/A ratio (SBP:
0.157, DBP: 0.217, MAP: 0.212; all p < 0.001),
Ell_SRe (SBP: 0.151, DBP: 0.181, MAP: 0.185; all
p < 0.001), and high E/e’ ratio (SBP: 0.183, DBP: 0.161,
MAP: 0.186; all p < 0.001) (Table 4, Online Table 5).
High cumulative exposure to SBP and PP was inde-
pendently associated with high left atrial volume
index (SBP: 0.068; p < 0.05; PP: 0.127; p < 0.001).LVMI attenuated the relationship of BP to LV diastolic
function parameters in Model 3, but use of antihy-
pertensive medications did not (Model 4).
DISCUSSION
This study demonstrates the effects of chronically
elevated BP—expressed as cumulative exposure to
hypertension from young adulthood to middle age—
TABLE 2 LV Systolic and Diastolic Dysfunction at Year 25 Predicted from Cumulative Exposure to SBP and DBP
n
Cumulative Exposure to SBP*
OR (95% CI)
Cumulative Exposure to DBP*
OR (95% CI)
Model 1 Model 2 Model 3 Model 4 Model 1 Model 2 Model 3 Model 4
Systolic dysfunction
(LVEF <50%)
70 1.37 (1.07–1.75) 1.14 (0.88–1.50) 1.04 (0.77–1.41) 1.15 (0.83–1.58) 1.25 (0.97–1.61) 1.00 (0.74–1.33) 0.92 (0.67–1.26) 0.99 (0.70–1.38)
Diastolic dysfunction
(E/e’ ratio >15)
69 1.68 (1.34–2.10) 1.66 (1.30–2.13) 1.41 (1.08–1.84) 1.46 (1.09–1.94) 1.86 (1.44–2.39) 1.89 (1.42–2.51) 1.62 (1.20–2.18) 1.69 (1.23–2.33)
Systolic or diastolic
dysfunction
135 1.57 (1.32–1.87) 1.45 (1.20–1.75) 1.30 (1.05–1.60) 1.38 (1.10–1.73) 1.53 (1.28–1.85) 1.40 (1.14–1.72) 1.26 (1.01–1.58) 1.34 (1.05–1.70)
Model 1 adjusted for age, race, sex, and ﬁeld center. Model 2 adjusted for Model 1 þ average body mass index (kg/m2), average physical activity (EU), educational level (year) at year 25, average alcohol intake
(ml), current smoking at year 25, average heart rate (beats/min), average total cholesterol (mg/dl), diabetes at year 25 (yes). Model 3 adjusted for Model 2 þ LV mass/body surface area at year 25 to the
systolic and diastolic indices. Model 4 adjusted for Model 3 þ antihypertensive medications at year 25 (yes). *Per SD increment.
CI ¼ conﬁdence interval; LV ¼ left ventricular; OR ¼ odds ratio; other abbreviations as in Table 1.
TABLE 3 Relationsh
M
Stan
LVEF, % 0.00
Ell, % 0.17
Ecc, % 0.04
Err, % 0.08
Ell_SRs, sec1 0.12
Ecc_SRs, sec1 0.0
Err_SRs, sec1 0.11
Models adjusted as indicat
BP ¼ blood pressure; SE
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documents a greater effect of cumulative BP exposure
on diastolic versus systolic myocardial function in a
population of healthy adults, with a greater effect of
diastolic as opposed to SBP elevation on both systolic
and diastolic LV dysfunction.
CUMULATIVE EFFECTS OF BP ON MYOCARDIAL
DEFORMATION. LV function has been reported to be
associated with the effects of hypertension and other
chronic factors such as obesity (13,18–21). In our
study, cumulative BP was not associated with
reduced LVEF (<50%); however, cumulative expo-
sure to elevated BP, especially high DBP and MAP,
was independently associated with reduced global
systolic myocardial LV function as assessed by Ell and
Ell_SRs. In addition, Ell_SRe was affected by mildly
elevated cumulative BP compared with E/e’ ratio,
which was affected by high cumulative BP exposure
(Central Illustration). Thus, Ell_SRe may be a good
predictor of diastolic LV dysfunction even when
compared with E/e’ ratio.
In an older population, the MESA (Multi-Ethnic
Study of Atherosclerosis) demonstrated a relationip of Cumulative Exposure to BP Over 25 Years to Systolic LV Functional
Cumulative Exposure to SBP
odel 1 Model 2 Model 3 Model 4
dardized b
(SE)
Standardized b
(SE)
Standardized b
(SE)
Standardized b
(SE)
S
1 (0.024) 0.039 (0.025) 0.016 (0.027) 0.005 (0.030) 0
5 (0.023)§ 0.097 (0.024)§ 0.086 (0.026)‡ 0.078 (0.029)† 0
6 (0.024)* 0.009 (0.025) 0.033 (0.026) 0.035 (0.029) 0
0 (0.024)‡ 0.098 (0.025)‡ 0.088 (0.027)‡ 0.118 (0.029)§ 0
7 (0.024)§ 0.112 (0.026)§ 0.081 (0.027)‡ 0.086 (0.030)‡
13 (0.024) 0.018 (0.025) 0.038 (0.027) 0.025 (0.029) 0
6 (0.024)§ 0.1004 (0.025)§ 0.097 (0.027)‡ 0.115 (0.029)§ 0
ed in Table 2. *p < 0.10. †p < 0.05. ‡p < 0.005. §p < 0.001.
¼ standard error; standardized b ¼ standardized b-coefﬁcients; other abbreviations as in Tbetween elevated DBP and decreased regional myo-
cardial function using cardiac magnetic resonance (5).
Likewise, high DBP at an older age was associated
with reduced longitudinal myocardial shortening as
measured by STE in the Framingham Study (22). In
hypertensive patients with LV hypertrophy and
normal ejection fraction, Palmon et al. (23) reported
reduced intramural (endocardial) longitudinal and
circumferential shortening. Worse longitudinal and
circumferential myocardial deformation also have
been associated with adverse outcomes (6).
Echocardiographic measurement of worsening of
longitudinal and circumferential strain mostly rep-
resents reduced longitudinal and circumferential
deformation of endocardial ﬁbers, respectively. This
may reﬂect a chronic process that begins with
cumulative BP effects increasing afterload and aortic
stiffness, thus increasing systolic LV wall stress
and inducing LV remodeling (4,24). Compensatory
mechanisms activated to maintain cardiac contrac-
tion include: 1) an increase in LV mass with concen-
tric remodeling (25); and 2) an increase in LV torsion
(4). Increased LV wall stress damages the oblique
ﬁber structure in the endocardium; this may leadIndices
Cumulative Exposure to DBP
Model 1 Model 2 Model 3 Model 4
tandardized b
(SE)
Standardized b
(SE)
Standardized b
(SE)
Standardized b
(SE)
.024 (0.023) 0.032 (0.025) 0.016 (0.027) 0.005 (0.029)
.218 (0.022)§ 0.132 (0.024)§ 0.120 (0.025)§ 0.119 (0.028)§
.086 (0.023)‡ 0.024 (0.025) 0.011 (0.026) 0.018 (0.028)
.015 (0.023) 0.039 (0.026) 0.026 (0.026) 0.043 (0.029)
0.125 (0.023)§ 0.125 (0.025)§ 0.099 (0.026)‡ 0.107 (0.029)‡
.014 (0.023) 0.016 (0.026) 0.0003 (0.026) 0.021 (0.029)
.064 (0.023)† 0.387 (0.026) 0.033 (0.027) 0.039 (0.029)
ables 1 and 2.
TABLE 4 Relationships of Cumulative Exposure to BP Over 25 Years to Diastolic LV Functional Indices
Cumulative Exposure to SBP Cumulative Exposure to DBP
Model 1 Model 2 Model 3 Model 4 Model 1 Model 2 Model 3 Model 4
Standardized b
(SE)
Standardized b
(SE)
Standardized b
(SE)
Standardized b
(SE)
Standardized b
(SE)
Standardized b
(SE)
Standardized b
(SE)
Standardized b
(SE)
E/A ratio 0.255 (0.022)§ 0.157 (0.022)§ 0.158 (0.024)§ 0.157 (0.027)§ 0.324 (0.021)§ 0.209 (0.022)§ 0.209 (0.024)§ 0.217 (0.027)§
e’, cm/s 0.271 (0.020)§ 0.208 (0.021)§ 0.148 (0.022)§ 0.127 (0.024)§ 0.322 (0.019)§ 0.266 (0.021)§ 0.225 (0.022)§ 0.218 (0.023)§
E/e’ ratio 0.260 (0.020)§ 0.227 (0.022)§ 0.183 (0.023)§ 0.183 (0.026)§ 0.226 (0.020)§ 0.200 (0.022)§ 0.165 (0.023)§ 0.161 (0.025)§
LAV/BSA, ml/m2 0.120 (0.022)§ 0.134 (0.023)§ 0.068 (0.024)‡ 0.068 (0.026)† 0.000 (0.022) 0.028 (0.024) 0.026 (0.024) 0.004 (0.026)*
Ell_SRe, sec1 0.186 (0.023)§ 0.162 (0.025)§ 0.139 (0.026)§ 0.151 (0.029)§ 0.200 (0.022)§ 0.185 (0.025)§ 0.167 (0.026)§ 0.181 (0.028)§
Ecc_SRe, sec1 0.05 (0024)† 0.003 (0.025) 0.020 (0.026) 0.020 (0.029) 0.066 (0.023)‡ 0.026 (0.025) 0.012 (0.026) 0.017 (0.028)
Err_SRe, sec1 0.016 (0.024)* 0.014 (0.025) 0.018 (0.027) 0.005 (0.030) 0.032 (0.023) 0.031 (0.026) 0.034 (0.027) 0.024 (0.029)
Models adjusted as indicated in Table 2. *p < 0.10. †p < 0.05. ‡p < 0.005. §p < 0.001.
Abbreviations as in Tables 1 and 3.
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2685to myocardial ﬁbrosis (26). Moreover, long-term
exposure to high BP stimulates reactive interstitial
ﬁbrosis, as shown in hypertensive cardiomyopathy
(25,27). Reduced subendocardial shortening, ob-
served in this study using STE, is the ﬁrst sign of
impairment of longitudinal myocardial function.
Compensation by mid-wall ﬁbers with resultant
improvement in radial contractility maintains overall
cardiac function and explains the lack of relation to
conventional systolic function parameters (28).
In young adulthood (before 40 years of age), aging is
associatedwith an increase in DBP and a decrease in PP
up to age 40 years (Central Illustration, Online Figure 1).
After age 40 years, aging is associated with a decrease
in DBP and an increase in PP; in the latter half of the
human life span SBP increases with each decade of life
(29,30). Of note, our ﬁndings show a turning point
for PP that occurs earlier than that demonstrated in
the Framingham Study (30). Furthermore, BP, espe-
cially elevated DBP, already produced worsening
myocardial function in healthy young adulthood. An
elevation in DBP may be useful as an outcome predic-
tor in young adulthood in contrast to the greater
importance of SBP in older individuals (31).
CLINICAL IMPLICATIONS. This study shows that the
use of speckle-tracking data and LV dysfunction help
us better understand the adverse effects of cumu-
lated BP exposure that ejection fraction alone does
not identify.
In prior CARDIA reports, Pletcher et al. (32) and
Allen et al. (33) demonstrated that a higher BP tra-
jectory beginning in young adulthood increased the
risk of the prevalence of coronary calcium in middle
age. These studies suggest that long-term BP control
in early young adulthood may be important to pre-
vent coronary heart disease. Our ﬁndings suggest that
the relationship of long-term exposure to higher BPand LV dysfunction is similar to that for subclinical
atherosclerosis and provides further support for the
importance of good risk factor control early in life. In
the CARDIA study, potentially modiﬁable anteced-
ents of HF were present in African Americans more
than a decade before the onset of clinical HF (31).
Each increase of 10 mm Hg in DBP among African
Americans 20 to 29 years of age had a 2-fold greater
risk for development of HF at 40 to 49 years of age.
Long-term treatment of both systolic and diastolic
hypertension reduces the risk of HF (34,35). Of
patients with hypertension, 20% to 30% are unaware
of their condition (36,37). In addition, 50% to 70% of
all patients with hypertension do not achieve their
target BP (36–38). In the National Longitudinal Study
of Adolescent Health, Nguyen et al. (39) reported that
approximately 1 in 5 young adults had high BP. In our
cohort, many participants were not hypertensive at
age 18 to 30 years; however, chronic exposure to
higher BP, even within what is considered the normal
range, is independently related to LV dysfunction
25 years later. Young adults may prevent the devel-
opment of LV dysfunction by reducing sodium intake,
keeping ideal body weight, and performing adequate
levels of physical activity, as well as by adhering to
medical treatment (40–42). Clinical trials of earlier
treatment for hypertension may be warranted to
determine whether favorable cardiac function can be
maintained by decreasing cumulative BP exposure.
Our ﬁndings and those of some previous studies
suggest that prehypertension throughout early
adulthood is harmful to cardiac function (4,20,22).
STUDY LIMITATIONS. We relied on a subclinical
endpoint (LV systolic and diastolic dysfunction
measured by echocardiography); our ﬁndings will
need validation using clinical endpoints. We did not
aim to expose the potential effect of differences
PERSPECTIVES
COMPETENCY IN MEDICAL KNOWLEDGE: BP in
early adulthood is related to later systolic and dia-
stolic ventricular dysfunction.
TRANSLATIONAL OUTLOOK: Further studies are
needed to determine whether speciﬁc lifestyle inter-
ventions implemented to reduce DBP in early adult-
hood prevent HF from developing later in life.
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2686between classes of antihypertensive medication on
LV function. Our participants were 18 to 30 years of
age at baseline (year 0); thus, our study could not
assess cumulative BP exposure at earlier ages. This
study was not designed to identify a speciﬁc BP early
in age that was associated with future myocardial
dysfunction. Also, all analyses were performed on a
single system (Toshiba Medical Systems). Recently,
the inter/intrasonographer reproducibility for STE
analysis using the Artida cardiac ultrasound scanner
in the CARDIA Study has been published (43). The
results were highly reproducible in this large cohort
study. However, recent publications have shown
signiﬁcant intervendor variability of strain (14).
CONCLUSIONS
Cumulative exposure to BP over 25 years from
young adulthood to middle age is associated with
incipient LV systolic and diastolic dysfunction in
middle age. In early adulthood, DBP control may be
of particular importance to prevent LV dysfunction
and HF.ACKNOWLEDGMENTS The authors thank the other
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